Susquehanna International Group
ENZN

Susquehanna International Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Susquehanna International Group’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24,074
Closed -$23K – 10440
2015
Q3 		$23K Buy
+24,074
New +$29.6K ﹤0.01% 9486
2014
Q3 		– Sell
-302,273
Closed -$314K – 10391
2014
Q2 		$314K Buy
+302,273
New +$288K ﹤0.01% 8304
2014
Q1 		– Sell
-10,645
Closed -$12K – 9799
2013
Q4 		$12K Buy
+10,645
New +$16.4K ﹤0.01% 8912
2013
Q3 		– Sell
-123,100
Closed -$246K – 9054
2013
Q2 		$246K Buy
+123,100
New +$360K ﹤0.01% 7140

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Susquehanna International Group's ENZN Position: Q4 2015 in Review

Susquehanna International Group sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2015, closing a stake of 24,074 shares — an estimated $23K sold.

Susquehanna International Group first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $314K in Q2 2014. 49 funds tracked by Wall St. Rank hold ENZN as of Q4 2015.

  • Susquehanna International Group reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
  • Susquehanna International Group sold 24,074 ENZON PHARMACEUTICALS INC shares in Q4 2015, an estimated $23K.
  • Susquehanna International Group first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Susquehanna International Group's ENZON PHARMACEUTICALS INC position peaked at $314K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.